| Study |
Reference |
|
Adab (Valproate), 2004
|
Adab The longer term outcome of children born to mothers with epilepsy. J. Neurol. Neurosurg. Psychiatry 2004; 75:1575-83 Kini U Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed 2006;91:F90-5 Vinten The behavioral consequences of exposure to antiepileptic drugs in utero. Epilepsy Behav 2009; 14:197-201
|
|
Al Bunyan (Valproate), 1999
|
Al Bunyan Outcome of pregnancies in epileptic women: a study in Saudi Arabia.,Outcome of pregnancies in epileptic women: a study in Saudi Arabia. Seizure 1999; 8:26-9
|
|
Alsaadi (Valproate) (Epilepsy) (Controls exposed to LTG), 2020
|
Alsaadi Antiseizure drugs use during pregnancy and congenital malformations: A retrospective review from the United Arab Emirates. Epilepsy Res 2020; 159:106259
|
|
Alsaadi (Valproate) (Epilepsy) (Controls unexposed sick), 2020
|
Alsaadi Antiseizure drugs use during pregnancy and congenital malformations: A retrospective review from the United Arab Emirates. Epilepsy Res 2020; 159:106259
|
|
Alsfouk (Valproate), 2022
|
Alsfouk, B.A. Patterns of antiseizure medication prescription in pregnancy and maternal complications in women with epilepsy: A retrospective study in Saudi Arabia Saudi Pharm. J. 2022; 30:205-.
|
|
Alsfouk (Valproate) (Controls exposed to Lamotrigine, sick), 2021
|
Alsfouk, B.A. Antiseizure medications use during pregnancy and congenital malformations: A retrospective study in Saudi Arabia Saudi Pharm. J. 2021; 29:939-.
|
|
Alsfouk (Valproate) (Controls unexposed, sick), 2021
|
Alsfouk, B.A. Antiseizure medications use during pregnancy and congenital malformations: A retrospective study in Saudi Arabia Saudi Pharm. J. 2021; 29:939-.
|
|
AlSheikh (Valproate) (Controls exposed to Lamotrigine, sick), 2020
|
AlSheikh Prevalence of epilepsy in Saudi pregnant women and possible effects of anti-epileptic drugs on pregnancy outcomes. Neurosciences (Riyadh) 2020; 25:32-37
|
|
AlSheikh (Valproate) (Controls unexposed, sick), 2020
|
AlSheikh Prevalence of epilepsy in Saudi pregnant women and possible effects of anti-epileptic drugs on pregnancy outcomes. Neurosciences (Riyadh) 2020; 25:32-37
|
|
Arkilo (Valproate), 2015
|
Arkilo D Pregnancy and neurodevelopmental outcomes with in-utero antiepileptic agent exposure. A pilot study. Eur J Paediatr Neurol 2015;19:37-40
|
|
Artama (Valproate), 2005
|
Artama M Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 2005;64:1874-8
|
|
Artama (Valproate) (Controls exposed to Lamotrigine, sick), 2013
|
Artama M Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland. Drug Saf 2013;36:359-69
|
|
Artama (Valproate) (Controls unexposed, disease free), 2013
|
Artama M Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland. Drug Saf 2013;36:359-69
|
|
Artama (Valproate) (Controls unexposed, sick), 2013
|
Artama M Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland. Drug Saf 2013;36:359-69
|
|
Arteaga-Vázquez (Valproate), 2012
|
Arteaga-Vázquez J [Congenital malformations in the offspring of epileptic mothers with and without anticonvulsant treatment]. Salud Publica Mex 2012;54:579-86
|
|
Aydin (Valproate) (Controls exposed to Lamotrigine, sick), 2020
|
Aydin, E. Retrospective evaluation of pregnancy outcomes with maternal epilepsy Journal of Clinical Obstetrics and Gynecology 2020; 30:20-.
|
|
Aydin (Valproate) (Controls unexposed, sick), 2020
|
Aydin, E. Retrospective evaluation of pregnancy outcomes with maternal epilepsy Journal of Clinical Obstetrics and Gynecology 2020; 30:20-.
|
|
Babic (Valproate), 2014
|
Babic Postnatal concerns in children born to women with juvenile myoclonic epilepsy. In: European Congress on Epileptology. vol. 55. Stockholm: Epilepsia; 2014: 128
|
|
Baker (Valproate) (Controls exposed to Lamotrigine, sick), 2015
|
Baker IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology 2015; 84:382-90 Bromley RL The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013;84:637-43 Meador Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N. Engl. J. Med. 2009; 360:1597-605 Meador KJ Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 2013;12:244-52
|
|
Baker (Valproate) (Controls unexposed, disease free), 2015
|
Baker IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology 2015; 84:382-90 Bromley RL The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013;84:637-43
|
|
Baker (Valproate) (Controls unexposed, sick), 2015
|
Baker IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology 2015; 84:382-90 Bromley RL The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013;84:637-43
|
|
Ban (Valproate) (Mixed indications) (Controls exposed to Lamotrigine, sick), 2015
|
Ban L Congenital Anomalies in Children of Mothers Taking Antiepileptic Drugs with and without Periconceptional High Dose Folic Acid Use: A Population-Based Cohort Study. PLoS One 2015;10:e0131130 Petersen Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies. Clin Epidemiol 2017; 9:95-103
|
|
Ban (Valproate) (Mixed indications) (Controls unexposed NOS), 2015
|
Ban L Congenital Anomalies in Children of Mothers Taking Antiepileptic Drugs with and without Periconceptional High Dose Folic Acid Use: A Population-Based Cohort Study. PLoS One 2015;10:e0131130 Petersen Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies. Clin Epidemiol 2017; 9:95-103
|
|
Bànhidy (Valproate), 2011
|
Bànhidy Efficacy of medical care of epileptic pregnant women based on the rate of congenital abnormalities in their offspring. Congenit Anom (Kyoto) 2011; 51:34-42
|
|
Bank (Valproate) (Mixed indications), 2017
|
Bank Placental passage of antiepileptic drugs at delivery and neonatal outcomes. Epilepsia 2017; 58:e82-e86
|
|
Battino (Valproate), 1992
|
Battino Malformations in offspring of 305 epileptic women: a prospective study. Acta Neurol. Scand. 1992; 85:204-7 Canger R Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 1999;40:1231-6
|
|
Battino (Valproate), 1999
|
Battino D Intrauterine growth in the offspring of epileptic women: a prospective multicenter study. Epilepsy Res 1999;36:53-60
|
|
Battino (Valproate) (Epilepsy), 2024
|
Battino Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy. JAMA Neurol 2024; 81:481-489 Tomson Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol 2018; 17:530-538 Tomson T Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17
|
|
Bech (Valproate) (Controls exposed to Lamotrigine, sick) (Mixed indications), 2018
|
Bech In utero exposure to antiepileptic drugs is associated with learning disabilities among offspring. J Neurol Neurosurg Psychiatry 2018; 89:1324-1331
|
|
Bech (Valproate) (Controls unexposed, sick) (Mixed indications), 2018
|
Bech In utero exposure to antiepileptic drugs is associated with learning disabilities among offspring. J Neurol Neurosurg Psychiatry 2018; 89:1324-1331
|
|
Bjørk (Valproate) (Controls exposed to Lamotrigine, sick), 2018
|
Bjørk Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero. JAMA Neurol 2018; 75:160-168
|
|
Bjørk (Valproate) (Controls exposed to Lamotrigine, sick) (Mixed indications), 2022
|
Bjork, M. Prenatal antiseizure medication exposure and risk of autism and intellectual disability. SCAN-AED: A Nordic cohort study Eur. J. Neurol. 2021; 28:105-. Bjørk Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability. JAMA Neurol 2022; : Daugaard Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones. JAMA Netw Open 2020; 3:e2025570
|
|
Bjørk (Valproate) (Controls unexposed NOS) (Mixed indications), 2022
|
Bjork, M. Prenatal antiseizure medication exposure and risk of autism and intellectual disability. SCAN-AED: A Nordic cohort study Eur. J. Neurol. 2021; 28:105-. Bjørk Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability. JAMA Neurol 2022; : Daugaard Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones. JAMA Netw Open 2020; 3:e2025570
|
|
Bjørk (Valproate) (Controls unexposed, disease free), 2018
|
Bjørk Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero. JAMA Neurol 2018; 75:160-168
|
|
Bjørk (Valproate) (Controls unexposed, sick), 2018
|
Bjørk Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero. JAMA Neurol 2018; 75:160-168
|
|
Bjørk (Valproate) (Controls unexposed, sick) (Mixed indications), 2022
|
Bjork, M. Prenatal antiseizure medication exposure and risk of autism and intellectual disability. SCAN-AED: A Nordic cohort study Eur. J. Neurol. 2021; 28:105-. Bjørk Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability. JAMA Neurol 2022; : Daugaard Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones. JAMA Netw Open 2020; 3:e2025570
|
|
Blotière (Valproate) (Controls exposed to Lamotrigine, sick) (Mixed indications), 2019
|
Blotière Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs. Neurology 2019; 93:e167-e180
|
|
Blotière (Valproate) (Controls unexposed NOS) (Mixed indications), 2019
|
Blotière Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs. Neurology 2019; 93:e167-e180
|
|
Borthen (Valproate) (Controls exposed to Lamotrigine, sick), 2010
|
Borthen Delivery outcome of women with epilepsy: a population-based cohort study. BJOG 2010; 117:1537-43
|
|
Borthen (Valproate) (Controls exposed to Lamotrigine, sick), 2011
|
Borthen Delivery outcome of women with epilepsy: a population-based cohort study. BJOG 2010; 117:1537-43 Borthen Obstetric outcome in women with epilepsy: a hospital-based, retrospective study. BJOG 2011; 118:956-65 Veiby Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J. Neurol. 2014; 261:579-88
|
|
Borthen (Valproate) (Controls unexposed, disease free), 2010
|
Borthen Delivery outcome of women with epilepsy: a population-based cohort study. BJOG 2010; 117:1537-43
|
|
Borthen (Valproate) (Controls unexposed, disease free), 2011
|
Borthen Delivery outcome of women with epilepsy: a population-based cohort study. BJOG 2010; 117:1537-43 Borthen Obstetric outcome in women with epilepsy: a hospital-based, retrospective study. BJOG 2011; 118:956-65 Veiby Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J. Neurol. 2014; 261:579-88
|
|
Borthen (Valproate) (Controls unexposed, sick), 2010
|
Borthen Delivery outcome of women with epilepsy: a population-based cohort study. BJOG 2010; 117:1537-43
|
|
Borthen (Valproate) (Controls unexposed, sick), 2011
|
Borthen Delivery outcome of women with epilepsy: a population-based cohort study. BJOG 2010; 117:1537-43 Borthen Obstetric outcome in women with epilepsy: a hospital-based, retrospective study. BJOG 2011; 118:956-65 Veiby Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J. Neurol. 2014; 261:579-88
|
|
Bromley (Valproate), 2016
|
Bromley RL Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate. Neurology 2016;87:1943-1953
|
|
Bromley (Valproate) (Controls exposed to Lamotrigine, sick), 2010
|
Baker IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology 2015; 84:382-90 Bromley Early cognitive development in children born to women with epilepsy: a prospective report. Epilepsia 2010; 51:2058-65 Bromley RL The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013;84:637-43
|
|
Bromley (Valproate) (Controls exposed to Lamotrigine, sick), 2013
|
Bromley Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008; 71:1923-4 Bromley RL The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013;84:637-43
|
|
Bromley (Valproate) (Controls unexposed, disease free), 2010
|
Baker IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology 2015; 84:382-90 Bromley Early cognitive development in children born to women with epilepsy: a prospective report. Epilepsia 2010; 51:2058-65 Bromley RL The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013;84:637-43 Shallcross Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology 2011; 76:383-9
|
|
Bromley (Valproate) (Controls unexposed, disease free), 2013
|
Bromley Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008; 71:1923-4 Bromley RL The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013;84:637-43
|
|
Bromley (Valproate) (Controls unexposed, sick), 2010
|
Baker IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology 2015; 84:382-90 Bromley Early cognitive development in children born to women with epilepsy: a prospective report. Epilepsia 2010; 51:2058-65 Bromley RL The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013;84:637-43
|
|
Bromley (Valproate) (Controls unexposed, sick), 2013
|
Bromley Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008; 71:1923-4 Bromley RL The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013;84:637-43
|
|
Burja (Valproate) (Controls unexposed, disease free), 2006
|
Burja The frequency of neonatal morbidity after exposure to antiepileptic drugs in utero: a retrospective population-based study. Wien. Klin. Wochenschr. 2006; 118 Suppl 2:12-6
|
|
Burja (Valproate) (Controls unexposed, sick), 2006
|
Burja The frequency of neonatal morbidity after exposure to antiepileptic drugs in utero: a retrospective population-based study. Wien. Klin. Wochenschr. 2006; 118 Suppl 2:12-6
|
|
Campbell (Valproate) (Controls exposed to Lamotrigine, sick), 2014
|
Campbell E Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J Neurol Neurosurg Psychiatry 2014;85:1029-34 Campbell E Recurrence risk of congenital malformations in infants exposed to antiepileptic drugs in utero. Epilepsia 2013;54:165-71 Morrow J Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-8 Morrow JI Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2009;80:506-11
|
|
Campbell (Valproate) (Controls unexposed, sick), 2014
|
Campbell E Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J Neurol Neurosurg Psychiatry 2014;85:1029-34 Morrow J Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-8
|
|
Canger (Valproate), 1999
|
Canger R Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 1999;40:1231-6
|
|
Cassina (Valproate) (Controls exposed to Lamotrigine, sick) (Mixed indications), 2013
|
Cassina M Pregnancy outcome in women exposed to antiepileptic drugs: teratogenic role of maternal epilepsy and its pharmacologic treatment. Reprod Toxicol 2013;39:50-7
|
|
Cassina (Valproate) (Controls unexposed, disease free) (Mixed indications), 2013
|
Cassina M Pregnancy outcome in women exposed to antiepileptic drugs: teratogenic role of maternal epilepsy and its pharmacologic treatment. Reprod Toxicol 2013;39:50-7
|
|
Charlton (Valproate), 2017
|
Bromley RL The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 2013;84:637-43 Charlton Sensitivity of the UK Clinical Practice Research Datalink to Detect Neurodevelopmental Effects of Medicine Exposure in Utero: Comparative Analysis of an Antiepileptic Drug-Exposed Cohort. Drug Saf 2017; 40:387-397
|
|
Charlton (Valproate) (Controls exposed to Lamotrigine, sick), 2011
|
Charlton RA Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations. Drug Saf 2011;34:157-71 Morrow J Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-8
|
|
Charlton (Valproate) (Controls unexposed, sick), 2011
|
Charlton RA Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations. Drug Saf 2011;34:157-71 Morrow J Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-8
|
|
Christensen (Valproate) (All indications) (Controls exposed to LTG), 2024
|
Christensen Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries. Lancet Reg Health Eur 2024; 38:100849 Dreier Prenatal exposure to antiseizure medication and intrauterine growth restriction in offspring of women with epilepsy Epilepsia 2021; 62(S3):3-364.
|
|
Christensen (Valproate) (All indications) (Controls unexposed, general population), 2024
|
Christensen Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries. Lancet Reg Health Eur 2024; 38:100849 Dreier Prenatal exposure to antiseizure medication and intrauterine growth restriction in offspring of women with epilepsy Epilepsia 2021; 62(S3):3-364.
|
|
Christensen (Valproate) (Controls exposed to Lamotrigine, sick) (Mixed indications), 2013
|
Christensen Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013; 309:1696-703
|
|
Christensen (Valproate) (Controls exposed to Lamotrigine, sick) (Mixed indications), 2015
|
Christensen J Apgar-score in children prenatally exposed to antiepileptic drugs: a population-based cohort study. BMJ Open 2015;5:e007425
|
|
Christensen (Valproate) (Controls unexposed NOS) (Mixed indications), 2013
|
Christensen Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013; 309:1696-703
|
|
Christensen (Valproate) (Controls unexposed NOS) (Mixed indications), 2015
|
Christensen J Apgar-score in children prenatally exposed to antiepileptic drugs: a population-based cohort study. BMJ Open 2015;5:e007425
|
|
Christensen (Valproate) (Controls unexposed, sick) (Mixed indications), 2015
|
Christensen J Apgar-score in children prenatally exposed to antiepileptic drugs: a population-based cohort study. BMJ Open 2015;5:e007425
|
|
Cohen (Valproate), 2011
|
Cohen Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years. Epilepsy Behav 2011; 22:240-6
|
|
Cohen (Valproate), 2013
|
Cohen Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years. Epilepsy Behav 2013; 29:308-15
|
|
Cohen (Valproate) (Controls exposed to Lamotrigine, sick) (Mixed indications), 2019
|
Cohen Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes. J Clin Psychiatry 2019; 80:
|
|
Cohen (Valproate) (Controls unexposed NOS) (Mixed indications), 2019
|
Cohen Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes. J Clin Psychiatry 2019; 80:
|
|
Cohen (Valproate) (Mixed indications) (Controls exposed to LTG), 2023
|
Christensen Prenatal exposure to valproate and risk of congenital malformations-Could we have known earlier?-A population-based cohort study. Epilepsia 2021; 62:2981-2993 Cohen Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations. Ann Neurol 2023; 93:551-562
|
|
Cohen (Valproate) (Mixed indications) (Controls unexposed, NOS), 2023
|
Christensen Prenatal exposure to valproate and risk of congenital malformations-Could we have known earlier?-A population-based cohort study. Epilepsia 2021; 62:2981-2993 Cohen Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations. Ann Neurol 2023; 93:551-562
|
|
Cornel (Valproate) (Indications NOS), 1996
|
Cornel Population-based birth-defect and risk-factor surveillance: data from the Northern Netherlands. Int J Risk Saf Med 1996; 8:197-209
|
|
Coste (Valproate) (Controls exposed to Lamotrigine, sick), 2020
|
Blotière Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a French nationwide population-based cohort study. BMJ Open 2020; 10:e034829 Coste Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France. Sci Rep 2020; 10:17362
|
|
Coste (Valproate) (Controls unexposed, NOS), 2020
|
Coste Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France. Sci Rep 2020; 10:17362
|
|
Cummings (Valproate) (Controls exposed to Lamotrigine, sick), 2011
|
Cummings C Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child 2011;96:643-7
|
|
Cummings (Valproate) (Controls unexposed, disease free), 2011
|
Cummings C Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child 2011;96:643-7
|
|
Czeizel (Valproate), 1992
|
Bànhidy Efficacy of medical care of epileptic pregnant women based on the rate of congenital abnormalities in their offspring. Congenit Anom (Kyoto) 2011; 51:34-42 Czeizel AE Evaluation of anticonvulsant drugs during pregnancy in a population-based Hungarian study. Eur J Epidemiol 1992;8:122-7
|
|
D'Souza (Valproate) (Controls unexposed, disease free), 1991
|
D'Souza SW Fetal phenytoin exposure, hypoplastic nails, and jitteriness. Arch Dis Child 1991;66:320-4
|
|
D'Souza (Valproate) (Controls unexposed, sick), 1991
|
D'Souza SW Fetal phenytoin exposure, hypoplastic nails, and jitteriness. Arch Dis Child 1991;66:320-4
|
|
Dean (Valproate), 2002
|
Dean Fetal anticonvulsant syndromes and polymorphisms in MTHFR, MTR, and MTRR. Am. J. Med. Genet. A 2007; 143A:2303-11 Dean JC Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 2002;39:251-9
|
|
Dean (Valproate) (Controls exposed to Lamotrigine, sick), 2007
|
Dean Fetal anticonvulsant syndromes and polymorphisms in MTHFR, MTR, and MTRR. Am. J. Med. Genet. A 2007; 143A:2303-11 Dean JC Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 2002;39:251-9
|
|
Dean (Valproate) (Controls unexposed, sick), 2007
|
Dean Fetal anticonvulsant syndromes and polymorphisms in MTHFR, MTR, and MTRR. Am. J. Med. Genet. A 2007; 143A:2303-11 Dean JC Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 2002;39:251-9
|
|
Deshmukh (Valproate), 2016
|
Deshmukh Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine. Neurotoxicol Teratol ; 54:5-14 Hernández-Díaz Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012;78:1692-9
|
|
Diav-Citrin (Valproate) (Mixed indications), 2008
|
Diav-Citrin Pregnancy outcome after in utero exposure to valproate : evidence of dose relationship in teratogenic effect. CNS Drugs 2008; 22:325-34
|
|
Díaz-Romero (Valproate), 1999
|
Díaz-Romero Facial anthropometric measurements in offspring of epileptic mothers. Arch. Med. Res. ; 30:186-9
|
|
Dravet (Valproate), 1992
|
Dravet Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. Neurology 1992; 42:75-82
|
|
Dreier (Valproate) (Epilepsy) (Controls exposed to LTG), 2023
|
Christensen Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring. JAMA Netw Open 2019; 2:e186606
|
|
Dreier (Valproate) (Epilepsy) (Controls unexposed, sick), 2023
|
Christensen Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring. JAMA Netw Open 2019; 2:e186606
|
|
Elkjaer (Valproate) (Controls exposed to Lamotrigine, sick) (Mixed indications), 2018
|
Elkjaer Association Between Prenatal Valproate Exposure and Performance on Standardized Language and Mathematics Tests in School-aged Children. JAMA Neurol 2018; 75:663-671
|
|
Elkjaer (Valproate) (Controls unexposed NOS) (Mixed indications), 2018
|
Elkjaer Association Between Prenatal Valproate Exposure and Performance on Standardized Language and Mathematics Tests in School-aged Children. JAMA Neurol 2018; 75:663-671
|
|
Endo (Valproate) (Controls unexposed, disease free), 2004
|
Endo Statistics on deliveries of mothers with epilepsy at Yokohama City University Hospital.,Statistics on deliveries of mothers with epilepsy at Yokohama City University Hospital. Epilepsia 2004; 45 Suppl 8:42-7
|
|
Endo (Valproate) (Controls unexposed, sick), 2004
|
Endo Statistics on deliveries of mothers with epilepsy at Yokohama City University Hospital.,Statistics on deliveries of mothers with epilepsy at Yokohama City University Hospital. Epilepsia 2004; 45 Suppl 8:42-7
|
|
Eriksson (Valproate), 2005
|
Eriksson Children exposed to valproate in utero--population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res. 2005; 65:189-200 Viinikainen The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children. Epilepsy Behav 2006; 9:636-40
|
|
Fietz (Valproate), 2024
|
Fietz Impact of maternal first trimester treatment regimen on the outcome of valproate exposed pregnancies: an observational Embryotox cohort study. Sci Rep 2024; 14:674
|
|
Gaily (Valproate) (Controls unexposed, disease free), 2004
|
Gaily Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004; 62:28-32
|
|
Gaily (Valproate) (Controls unexposed, sick), 2004
|
Gaily Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004; 62:28-32
|
|
Guveli (Valproate) (Epilepsy), 2017
|
Guveli Teratogenicity of Antiepileptic Drugs. Clin Psychopharmacol Neurosci 2017; 15:19-27
|
|
Hao (Valproate) (Epilepsy) (Controls exposed to LTG), 2025
|
Hao Seizure control and pregnancy outcomes in Chinese women with epilepsy: A prospective multicenter cohort study. Epilepsia 2025; :
|
|
Hao (Valproate) (Epilepsy) (Controls unexposed, sick), 2025
|
Hao Seizure control and pregnancy outcomes in Chinese women with epilepsy: A prospective multicenter cohort study. Epilepsia 2025; :
|
|
Hernández-Díaz (Valproate), 2012
|
Hernández-Díaz Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012;78:1692-9
|
|
Hernandez-Diaz (Valproate) (Epilepsy) (Controls exposed to LTG), 2024
|
Hernandez-Diaz Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure. N Engl J Med 2024; 390:1069-1079
|
|
Hernandez-Diaz (Valproate) (Epilepsy) (Controls unexposed, sick), 2024
|
Hernandez-Diaz Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure. N Engl J Med 2024; 390:1069-1079
|
|
Hosny (Valproate) (Controls exposed to Lamotrigine, sick), 2021
|
Hosny Risk factors of fetal deaths and major birth defects in newborns of women with epilepsy: An Egyptian prospective study. Epilepsy Behav 2021; 123:108251
|
|
Hosny (Valproate) (Controls unexposed, sick), 2021
|
Hosny Risk factors of fetal deaths and major birth defects in newborns of women with epilepsy: An Egyptian prospective study. Epilepsy Behav 2021; 123:108251
|
|
Huber-Mollema (Valproate), 2019
|
Huber-Mollema Behavioral problems in children of mothers with epilepsy prenatally exposed to valproate, carbamazepine, lamotrigine, or levetiracetam monotherapy. Epilepsia 2019; 60:1069-1082
|
|
Husebye (Valproate) (Controls exposed to Lamotrigine, sick), 2020
|
Husebye Language impairment in children aged 5 and 8 years after antiepileptic drug exposure in utero - the Norwegian Mother and Child Cohort Study. Eur J Neurol 2020; 27:667-675
|
|
Husebye (Valproate) (Controls unexposed, disease free), 2020
|
Husebye Language impairment in children aged 5 and 8 years after antiepileptic drug exposure in utero - the Norwegian Mother and Child Cohort Study. Eur J Neurol 2020; 27:667-675
|
|
Husebye (Valproate) (Controls unexposed, sick), 2020
|
Husebye Language impairment in children aged 5 and 8 years after antiepileptic drug exposure in utero - the Norwegian Mother and Child Cohort Study. Eur J Neurol 2020; 27:667-675
|
|
Hvas (Valproate) (Controls unexposed, disease free), 2000
|
Hvas CL Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. BJOG 2000;107:896-902
|
|
Hvas (Valproate) (Controls unexposed, sick), 2000
|
Hvas CL Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. BJOG 2000;107:896-902
|
|
Jäger-Roman (Valproate), 1986
|
Jäger-Roman Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J. Pediatr. 1986; 108:997-1004
|
|
Kaaja (Valproate), 2003
|
Kaaja E Major malformations in offspring of women with epilepsy. Neurology 2003;60:575-9
|
|
Källén (Valproate), 1994
|
Källén Maternal carbamazepine and infant spina bifida. Reprod Toxicol ; 8:203-5
|
|
Källén (Valproate) (Controls exposed to Lamotrigine, sick) (Indications NOS), 2013
|
Bodén Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study. BMJ 2012; 345:e7085 Källén B The use of central nervous system active drugs during pregnancy. Pharmaceuticals (Basel) 2013;6:1221-86 Razaz N Association Between Pregnancy and Perinatal Outcomes Among Women With Epilepsy. JAMA Neurol 2017;74:983-991 Wide K Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr 2004;93:174-6
|
|
Källén (Valproate) (Controls unexposed, NOS) (Indications NOS), 2013
|
Bodén Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study. BMJ 2012; 345:e7085 Källén B The use of central nervous system active drugs during pregnancy. Pharmaceuticals (Basel) 2013;6:1221-86
|
|
Kaneko (Valproate), 1999
|
Battino Malformations in offspring of 305 epileptic women: a prospective study. Acta Neurol. Scand. 1992; 85:204-7 Canger R Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 1999;40:1231-6 Dansky Major congenital malformations in the offspring of epileptic patients: genetic and environmental risk factors. In: Epilepsy, Pregnancy and the Child. edn. Edited by Janz D, Bossi L, Dam M, Helge H, Richens A, Schmidt D. New York: Raven Press; 1982 Kaneko Teratogenicity of Antiepileptic Drugs: A Prospective Study. Japanese Journal of Psychiatry and Neurology. 1986;40(3):447-450. Kaneko Malformation in infants of mothers with epilepsy receiving antiepileptic drugs.,Malformation in infants of mothers with epilepsy receiving antiepileptic drugs. Neurology 1992; 42:68-74 Kaneko S Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999;33:145-58 Kaneko S Teratogenicity of antiepileptic drugs: analysis of possible risk factors. Epilepsia 1988;29:459-67 Oguni Improved pregnancy outcome in epileptic women in the last decade: relationship to maternal anticonvulsant therapy. Brain Dev. 1992; 14:371-80
|
|
Kasradze (Valproate) (Controls exposed to Lamotrigine, sick), 2017
|
Kasradze S Cognitive functions in children exposed to antiepileptic drugs in utero - Study in Georgia. Epilepsy Behav 2017;66:105-112
|
|
Kasradze (Valproate) (Controls unexposed, disease free), 2017
|
Kasradze S Cognitive functions in children exposed to antiepileptic drugs in utero - Study in Georgia. Epilepsy Behav 2017;66:105-112
|
|
Katz (Valproate), 2001
|
Katz Current Management of Epilepsy and Pregnancy: Fetal Outcome, Congenital Malformations, and Developmental Delay.,Current Management of Epilepsy and Pregnancy: Fetal Outcome, Congenital Malformations, and Developmental Delay. Epilepsy Behav 2001; 2:119-123
|
|
Kilic (Valproate) (Controls exposed to Lamotrigine, sick) (Mixed indications), 2014
|
Kilic D Birth outcomes after prenatal exposure to antiepileptic drugs--a population-based study. Epilepsia 2014;55:1714-21
|
|
Kilic (Valproate) (Controls unexposed NOS) (Mixed indications), 2014
|
Kilic D Birth outcomes after prenatal exposure to antiepileptic drugs--a population-based study. Epilepsia 2014;55:1714-21
|
|
Kilic (Valproate) (Controls unexposed, sick) (Mixed indications), 2014
|
Kilic D Birth outcomes after prenatal exposure to antiepileptic drugs--a population-based study. Epilepsia 2014;55:1714-21
|
|
Kini (Valproate) (Controls exposed to Lamotrigine, sick), 2006
|
Kini U Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed 2006;91:F90-5
|
|
Kini (Valproate) (Controls unexposed, sick), 2006
|
Adab The longer term outcome of children born to mothers with epilepsy. J. Neurol. Neurosurg. Psychiatry 2004; 75:1575-83 Kini U Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed 2006;91:F90-5
|
|
Koch (Valproate), 1996
|
Jäger-Roman Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J. Pediatr. 1986; 108:997-1004 Koch S Antiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcome. Acta Paediatr 1996;85:739-46
|
|
Leite (Valproate) (Epilepsy), 2024
|
Leite Obstetric and neonatal outcomes, antiseizure medication profile, and seizure types in pregnant women in a vulnerability state from Brazil. PLoS One 2024; 19:e0291190
|
|
Li (Valproate) (Controls exposed to LTG), 2023
|
He Pregnancy outcome in women with epilepsy in Western China: A prospective hospital based study. Epilepsy Behav 2017; 74:10-14 Li Pregnancy characteristics and adverse outcomes in offspring of women with epilepsy: a prospective registry study from Mainland China. Front Neurol 2023; 14:1195003
|
|
Li (Valproate) (Controls unexposed, sick), 2023
|
He Pregnancy outcome in women with epilepsy in Western China: A prospective hospital based study. Epilepsy Behav 2017; 74:10-14 Li Pregnancy characteristics and adverse outcomes in offspring of women with epilepsy: a prospective registry study from Mainland China. Front Neurol 2023; 14:1195003
|
|
Madley-Dowd_SE (Valproate) (Controls exposed to LTG) (Mixed indications), 2024
|
Madley-Dowd Antiseizure medication use during pregnancy and children's neurodevelopmental outcomes. Nat Commun 2024; 15:9640
|
|
Madley-Dowd_SE (Valproate) (Controls unexposed, general pop) (Mixed indications), 2024
|
Madley-Dowd Antiseizure medication use during pregnancy and children's neurodevelopmental outcomes. Nat Commun 2024; 15:9640
|
|
Madley-Dowd_SE (Valproate) (Controls unexposed, sibling) (Mixed indications), 2024
|
Madley-Dowd Antiseizure medication use during pregnancy and children's neurodevelopmental outcomes. Nat Commun 2024; 15:9640
|
|
Madley-Dowd_UK (Valproate) (Controls exposed to LTG) (Mixed indications), 2024
|
Madley-Dowd Antiseizure medication use during pregnancy and children's neurodevelopmental outcomes. Nat Commun 2024; 15:9640
|
|
Madley-Dowd_UK (Valproate) (Controls unexposed, general pop) (Mixed indications), 2024
|
Madley-Dowd Antiseizure medication use during pregnancy and children's neurodevelopmental outcomes. Nat Commun 2024; 15:9640
|
|
Madley-Dowd_UK (Valproate) (Controls unexposed, sibling) (Mixed indications), 2024
|
Madley-Dowd Antiseizure medication use during pregnancy and children's neurodevelopmental outcomes. Nat Commun 2024; 15:9640
|
|
Margulis (Valproate) (Mixed indications), 2019
|
Margulis Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth. PLoS One 2019; 14:e0214180
|
|
Mawer (Valproate) (Controls exposed to Lamotrigine, sick), 2010
|
Kini Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero.,Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero. Eur J Med Genet ; 50:411-20 Mawer G Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure 2010;19:112-9 Meador KJ In utero antiepileptic drug exposure: fetal death and malformations. Neurology 2006;67:407-12
|
|
Mawer (Valproate) (Controls unexposed, disease free), 2010
|
Kini Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero.,Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero. Eur J Med Genet ; 50:411-20 Mawer G Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure 2010;19:112-9
|
|
Mawer (Valproate) (Controls unexposed, sick), 2010
|
Kini Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero.,Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero. Eur J Med Genet ; 50:411-20 Mawer G Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure 2010;19:112-9
|
|
McVearry (Valproate), 2009
|
McVearry A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy. Epilepsy Behav 2009; 16:609-16
|
|
Meador (Valproate), 2006
|
Mawer G Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure 2010;19:112-9 Meador KJ In utero antiepileptic drug exposure: fetal death and malformations. Neurology 2006;67:407-12
|
|
Meador (Valproate), 2009
|
Baker IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology 2015; 84:382-90 Meador Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N. Engl. J. Med. 2009; 360:1597-605 Meador Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure. Epilepsy Behav 2011; 21:147-52 Meador KJ Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 2013;12:244-52
|
|
Meador (Valproate), 2011
|
Meador Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain 2011; 134:396-404
|
|
Meador (Valproate), 2013
|
Baker IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology 2015; 84:382-90 Cohen Fetal antiepileptic drug exposure and learning and memory functioning at 6?years of age: The NEAD prospective observational study. Epilepsy Behav 2019; 92:154-164 Meador Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N. Engl. J. Med. 2009; 360:1597-605 Meador Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain 2011; 134:396-404 Meador Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure. Epilepsy Behav 2011; 21:147-52 Meador Effects of periconceptional folate on cognition in children of women with epilepsy: NEAD study. Neurology 2020; 94:e729-e740 Meador KJ Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 2013;12:244-52
|
|
Miškov (Valproate) (Controls exposed to Lamotrigine, sick), 2016
|
Miskov S, Juraski RG, Fucic A, et al. Croatian Pregnant Women with Epilepsy and Effects of Antiepileptic Drugs Exposure in their Offspring - seven years of prospective surveillance. . American Epilepsy Society; Texas 2010 Miškov The Croatian Model of Integrative Prospective Management of Epilepsy and Pregnancy Acta Clin Croat 2016; 55:535-548
|
|
Miškov (Valproate) (Controls unexposed, disease free), 2016
|
Miskov S, Juraski RG, Fucic A, et al. Croatian Pregnant Women with Epilepsy and Effects of Antiepileptic Drugs Exposure in their Offspring - seven years of prospective surveillance. . American Epilepsy Society; Texas 2010 Miškov The Croatian Model of Integrative Prospective Management of Epilepsy and Pregnancy Acta Clin Croat 2016; 55:535-548
|
|
Miškov (Valproate) (Controls unexposed, sick), 2016
|
Miskov S, Juraski RG, Fucic A, et al. Croatian Pregnant Women with Epilepsy and Effects of Antiepileptic Drugs Exposure in their Offspring - seven years of prospective surveillance. . American Epilepsy Society; Texas 2010 Miškov The Croatian Model of Integrative Prospective Management of Epilepsy and Pregnancy Acta Clin Croat 2016; 55:535-548
|
|
Nadebaum (Valproate), 2011
|
Nadebaum Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology 2011; 76:719-26
|
|
Pekoz (Valproate) (Epilepsy) (Controls exposed to LTG), 2023
|
Pekoz Birth outcomes in pregnant women with epilepsy: A Nationwide multicenter study from Turkiye. Epilepsia 2023; 64:2310-2321
|
|
Pekoz (Valproate) (Epilepsy) (Controls unexposed, sick), 2023
|
Pekoz Birth outcomes in pregnant women with epilepsy: A Nationwide multicenter study from Turkiye. Epilepsia 2023; 64:2310-2321
|
|
Pennell (Valproate), 2012
|
Pennell Differential effects of antiepileptic drugs on neonatal outcomes.,Differential effects of antiepileptic drugs on neonatal outcomes. Epilepsy Behav 2012; 24:449-56
|
|
Petersen (Valproate) (Controls exposed to Lamotrigine, sick), 2017
|
Petersen Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies. Clin Epidemiol 2017; 9:95-103
|
|
Petersen (Valproate) (Controls unexposed NOS), 2017
|
Petersen Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies. Clin Epidemiol 2017; 9:95-103
|
|
Petersen (Valproate) (Controls unexposed, sick), 2017
|
Petersen Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies. Clin Epidemiol 2017; 9:95-103
|
|
Putignano (Valproate), 2019
|
Putignano Perinatal outcome and healthcare resource utilization in the first year of life after antiepileptic exposure during pregnancy. Epilepsy Behav 2019; 92:14-17
|
|
Razaz (Valproate) (Epilepsy), 2024
|
Razaz Risk of Perinatal and Maternal Morbidity and Mortality Among Pregnant Women With Epilepsy. JAMA Neurol 2024; 81:985-995
|
|
Ren (Valproate) (Mixed indications), 2023
|
Elkjaer Association Between Prenatal Valproate Exposure and Performance on Standardized Language and Mathematics Tests in School-aged Children. JAMA Neurol 2018; 75:663-671 Ren Prenatal Carbamazepine Exposure and Academic Performance in Adolescents: A Population-Based Cohort Study. Neurology 2023; 100:e728-e738
|
|
Richards (Valproate) (Controls exposed to Lamotrigine, sick) (Indications NOS), 2019
|
Richards Developmental outcomes at age four following maternal antiepileptic drug use. Epilepsy Behav 2019; 93:73-79
|
|
Richards (Valproate) (Controls unexposed, NOS) (Indications NOS), 2019
|
Richards Developmental outcomes at age four following maternal antiepileptic drug use. Epilepsy Behav 2019; 93:73-79
|
|
Rihtman (Valproate) (Controls exposed to Lamotrigine, sick) (Mixed indications), 2013
|
Rihtman Developmental outcomes at preschool age after fetal exposure to valproic acid and lamotrigine: cognitive, motor, sensory and behavioral function. Reprod. Toxicol. 2013; 41:115-25
|
|
Rihtman (Valproate) (Controls unexposed, NOS) (Mixed indications), 2013
|
Rihtman Developmental outcomes at preschool age after fetal exposure to valproic acid and lamotrigine: cognitive, motor, sensory and behavioral function. Reprod. Toxicol. 2013; 41:115-25
|
|
Robert (Valproate), 1986
|
Robert Evaluation of drug therapy and teratogenic risk in a Rhône-Alpes district population of pregnant epileptic women. Eur. Neurol. 1986; 25:436-43
|
|
Samrén (Valproate), 1999
|
Samrén Antiepileptic drug regimens and major congenital abnormalities in the offspring.,Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann. Neurol. 1999; 46:739-46
|
|
Shallcross (Valproate), 2011
|
Bromley Early cognitive development in children born to women with epilepsy: a prospective report. Epilepsia 2010; 51:2058-65 Shallcross Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology 2011; 76:383-9
|
|
Steegers-Theunissen (Valproate), 1994
|
Steegers-Theunissen Factors influencing the risk of abnormal pregnancy outcome in epileptic women: a multi-centre prospective study.,Factors influencing the risk of abnormal pregnancy outcome in epileptic women: a multi-centre prospective study. Epilepsy Res. 1994; 18:261-9
|
|
Stjerna (Valproate) (Epilepsy), 2024
|
Huber-Mollema Neurocognition after prenatal levetiracetam, lamotrigine, carbamazepine or valproate exposure. J Neurol 2020; 267:1724-1736 Stjerna Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol. Epilepsy Behav 2024; 159:110024
|
|
The NAAED (Valproate) (Controls exposed to LTG) (Indications NOS), 2023
|
Hernández-Díaz Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012;78:1692-9 Lewis B. Holmes, M.D. (Director) Risk of malformations for specific AED in monotherapy and the control groups (Latest Study Data - October 2023) https://www.aedpregnancyregistry.org/ (Consulted 05/2022) Lewis Holmes Risk of malformations for specific AED in monotherapy and the control groups. Latest Study Data - October 2023. https://www.aedpregnancyregistry.org/ (Consulted September 2024)
|
|
The NAAED (Valproate) (Controls unexposed, disease free) (Indications NOS), 2023
|
Hernández-Díaz Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012;78:1692-9 Lewis B. Holmes, M.D. (Director) Risk of malformations for specific AED in monotherapy and the control groups (Annual Update for 2022) https://www.aedpregnancyregistry.org/ (Consulted 05/2022) Lewis Holmes Risk of malformations for specific AED in monotherapy and the control groups. Latest Study Data - October 2023. https://www.aedpregnancyregistry.org/ (Consulted September 2024) Wyszynski Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 2005; 64:961-5
|
|
Thomas (Valproate) (Controls exposed to Lamotrigine, sick), 2021
|
Keni Teratogenicity of antiepileptic dual therapy: Dose-dependent, drug-specific, or both? Neurology 2018; 90:e790-e796 Thomas Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India. Epilepsia 2017; 58:274-281 Thomas Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP). Seizure 2021; 93:127-132
|
|
Thomas (Valproate) (Controls unexposed, disease free), 2021
|
Thomas Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India. Epilepsia 2017; 58:274-281
|
|
Thomas (Valproate) (Controls unexposed, sick), 2021
|
Thomas Cardiac malformations are increased in infants of mothers with epilepsy. Pediatr Cardiol 2008; 29:604-8 Thomas Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India. Epilepsia 2017; 58:274-281 Thomas Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP). Seizure 2021; 93:127-132
|
|
Thomas a (Valproate), 2008
|
Thomas Cardiac malformations are increased in infants of mothers with epilepsy.,Cardiac malformations are increased in infants of mothers with epilepsy. Pediatr Cardiol 2008; 29:604-8
|
|
Thomas a (Valproate), 2022
|
Bhaskaran Neurobehavioral Outcomes of Children with Antenatal Exposure to Antiseizure Medications. Indian J Pediatr 2025; 92:252-259 Gopinath Children (10-12 years age) of women with epilepsy have lower intelligence, attention and memory: Observations from a prospective cohort case control study. Epilepsy Res 2015; 117:58-62 Sreedharan Reduced brain volumes in children of women with epilepsy: A neuropsychological and voxel based morphometric analysis in pre-adolescent children. J Neuroradiol 2018; 45:380-385 Thomas Intellectual and language functions in children of mothers with epilepsy. Epilepsia 2007; 48:2234-40
|
|
Thomas b (Valproate) (Epilepsy) (Controls exposed to LTG), 2022
|
Bhaskaran Neurobehavioral Outcomes of Children with Antenatal Exposure to Antiseizure Medications. Indian J Pediatr 2025; 92:252-259 Thomas Motor and mental development of infants exposed to antiepileptic drugs in utero. Epilepsy Behav 2008; 13:229-36 Thomas, S.V. Differential impact of antenatal exposure to antiseizure medications on motor and mental development in infants of women with epilepsy Epileptic Disord. 2022; 24:531-.
|
|
Thomas b (Valproate) (Epilepsy) (Controls unexposed, sick), 2022
|
Bhaskaran Neurobehavioral Outcomes of Children with Antenatal Exposure to Antiseizure Medications. Indian J Pediatr 2025; 92:252-259 Thomas Motor and mental development of infants exposed to antiepileptic drugs in utero. Epilepsy Behav 2008; 13:229-36 Thomas, S.V. Differential impact of antenatal exposure to antiseizure medications on motor and mental development in infants of women with epilepsy Epileptic Disord. 2022; 24:531-.
|
|
Titze (Valproate) (Controls unexposed, disease free), 2008
|
Titze Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development. Dev Med Child Neurol 2008; 50:117-22
|
|
Titze (Valproate) (Controls unexposed, sick), 2008
|
Titze Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development. Dev Med Child Neurol 2008; 50:117-22
|
|
Tomson (Valproate), 2018
|
Martinez Ferri Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine. Neurologia 2018; 33:78-84 Martínez Ferri M [Malformations and fetal death in the Spanish antiepileptic drug and pregnancy registry: results at 6 years]. Neurologia 2009;24:360-5 Tomson Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol 2018; 17:530-538 Tomson T Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17
|
|
Tomson (Valproate), 2015
|
Tomson T Antiepileptic drugs and intrauterine death: A prospective observational study from EURAP. Neurology 2015;85:580-8
|
|
Trivedi (Valproate) (Controls exposed to Lamotrigine, sick), 2018
|
Trivedi Spontaneous fetal loss in women with epilepsy: prospective data from pregnancy registry in India. Epilepsy Res 2018; 146:50-53
|
|
Trivedi (Valproate) (Controls unexposed, sick), 2018
|
Trivedi Spontaneous fetal loss in women with epilepsy: prospective data from pregnancy registry in India. Epilepsy Res 2018; 146:50-53
|
|
Vajda (Valproate) (Controls exposed to Lamotrigine, sick), 2013
|
Vajda Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register. Seizure 2019; 65:6-11 Vajda Associations between particular types of fetal malformation and antiepileptic drug exposure in utero. Acta Neurol. Scand. 2013; 128:228-34
|
|
Vajda (Valproate) (Controls unexposed, sick), 2013
|
Vajda Associations between particular types of fetal malformation and antiepileptic drug exposure in utero. Acta Neurol Scand 2013; 128:228-34 Vajda Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register. Seizure 2019; 65:6-11
|
|
Vajda a (Valproate) (Controls exposed to LTG) (Epilepsy), 2024
|
Vajda Pregnancy, antiseizure medications and unexplained intrauterine foetal death. Epilepsy Behav 2024; 153:109724 Vajda Anti-epileptic drug exposure and risk of foetal death in utero. Acta Neurol Scand 2018; 137:20-23
|
|
Vajda a (Valproate) (Controls unexposed sick) (Epilepsy), 2024
|
Vajda Pregnancy, antiseizure medications and unexplained intrauterine foetal death. Epilepsy Behav 2024; 153:109724 Vajda Anti-epileptic drug exposure and risk of foetal death in utero. Acta Neurol Scand 2018; 137:20-23
|
|
Vajda b (Valproate) (Epilepsy) (Controls exposed to Lamotrigine, sick), 2024
|
Vajda Teratogenicity of the newer antiepileptic drugs--the Australian experience. J Clin Neurosci 2012; 19:57-9 Vajda Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register. Seizure 2010; 19:558-61 Vajda The prescribing of antiepileptic drugs for pregnant Australian women. Aust N Z J Obstet Gynaecol 2012; 52:49-53 Vajda Associations between particular types of fetal malformation and antiepileptic drug exposure in utero. Acta Neurol Scand 2013; 128:228-34 Vajda The teratogenic risk of antiepileptic drug polytherapy. Epilepsia 2010; 51:805-10 Vajda The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies. Aust N Z J Obstet Gynaecol 2007; 47:468-74 Vajda Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register. Seizure 2019; 65:6-11 Vajda The teratogenicity of the newer antiepileptic drugs - an update. Acta Neurol Scand 2014; 130:234-8 Vajda The teratogenesis risk associated with antiseizure medication duotherapy in women with epilepsy. Epilepsy Res 2024; 200:107316
|
|
Vajda b (Valproate) (Epilepsy) (Controls unexposed, sick), 2024
|
Vajda Teratogenicity of the newer antiepileptic drugs--the Australian experience. J Clin Neurosci 2012; 19:57-9 Vajda Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register. Seizure 2010; 19:558-61 Vajda The prescribing of antiepileptic drugs for pregnant Australian women. Aust N Z J Obstet Gynaecol 2012; 52:49-53 Vajda Associations between particular types of fetal malformation and antiepileptic drug exposure in utero. Acta Neurol Scand 2013; 128:228-34 Vajda The teratogenic risk of antiepileptic drug polytherapy. Epilepsia 2010; 51:805-10 Vajda The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies. Aust N Z J Obstet Gynaecol 2007; 47:468-74 Vajda Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register. Seizure 2019; 65:6-11 Vajda The teratogenicity of the newer antiepileptic drugs - an update. Acta Neurol Scand 2014; 130:234-8 Vajda The teratogenesis risk associated with antiseizure medication duotherapy in women with epilepsy. Epilepsy Res 2024; 200:107316
|
|
Vanya (Valproate) (Controls exposed to Lamotrigine, sick), 2015
|
Vanya EFFECTS OF MATERNAL EPILEPSY AND ANTIEPILEPTIC THERAPY IN WOMEN DURING PREGNANCY. Ideggyogy Sz 2015; 68:105-12
|
|
Vanya (Valproate) (Controls unexposed, sick), 2015
|
Vanya EFFECTS OF MATERNAL EPILEPSY AND ANTIEPILEPTIC THERAPY IN WOMEN DURING PREGNANCY. Ideggyogy Sz 2015; 68:105-12
|
|
Veiby (Valproate) (Controls exposed to Lamotrigine, sick) (Mixed indications), 2014
|
Veiby Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J. Neurol. 2014; 261:579-88
|
|
Veiby (Valproate) (Controls exposed to Lamotrigine, sick) a, 2013
|
Bjørk Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero. JAMA Neurol 2018; 75:160-168 Veiby G Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy. JAMA Neurol 2013;70:1367-74
|
|
Veiby (Valproate) (Controls exposed to Lamotrigine, sick) b, 2013
|
Bjørk Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero. JAMA Neurol 2018; 75:160-168 Farmen AH Intrauterine growth retardation in foetuses of women with epilepsy. Seizure 2015;28:76-80 Veiby Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J. Neurol. 2014; 261:579-88 Veiby G Exposure to antiepileptic drugs in utero and child development: a prospective population-based study. Epilepsia 2013;54:1462-72
|
|
Veiby (Valproate) (Controls unexposed, disease free) (Mixed indications), 2014
|
Veiby Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J. Neurol. 2014; 261:579-88
|
|
Veiby (Valproate) (Controls unexposed, disease free) a, 2013
|
Bjørk Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero. JAMA Neurol 2018; 75:160-168 Veiby G Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy. JAMA Neurol 2013;70:1367-74
|
|
Veiby (Valproate) (Controls unexposed, disease free) b, 2013
|
Bjørk Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero. JAMA Neurol 2018; 75:160-168 Farmen AH Intrauterine growth retardation in foetuses of women with epilepsy. Seizure 2015;28:76-80 Veiby Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J. Neurol. 2014; 261:579-88 Veiby G Exposure to antiepileptic drugs in utero and child development: a prospective population-based study. Epilepsia 2013;54:1462-72
|
|
Veiby (Valproate) (Controls unexposed, sick) (Mixed indications), 2014
|
Veiby Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J. Neurol. 2014; 261:579-88
|
|
Veiby (Valproate) (Controls unexposed, sick) a, 2013
|
Bjørk Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero. JAMA Neurol 2018; 75:160-168 Veiby G Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: a prospective cohort study on children of women with epilepsy. JAMA Neurol 2013;70:1367-74
|
|
Veiby (Valproate) (Controls unexposed, sick) b, 2013
|
Bjørk Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero. JAMA Neurol 2018; 75:160-168 Farmen AH Intrauterine growth retardation in foetuses of women with epilepsy. Seizure 2015;28:76-80 Veiby Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J. Neurol. 2014; 261:579-88 Veiby G Exposure to antiepileptic drugs in utero and child development: a prospective population-based study. Epilepsia 2013;54:1462-72
|
|
Videman (Valproate) (Controls exposed to Lamotrigine, sick), 2016
|
Videman Evidence for spared attention to faces in 7-month-old infants after prenatal exposure to antiepileptic drugs. Epilepsy Behav 2016; 64:62-68
|
|
Videman (Valproate) (Controls unexposed, disease free), 2016
|
Videman Evidence for spared attention to faces in 7-month-old infants after prenatal exposure to antiepileptic drugs. Epilepsy Behav 2016; 64:62-68
|
|
Viinikainen (Valproate) (Controls unexposed, disease free) a, 2006
|
Viinikainen Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia 2006; 47:186-92
|
|
Viinikainen (Valproate) (Controls unexposed, sick) a, 2006
|
Viinikainen Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia 2006; 47:186-92
|
|
Viinikainen (Valproate) b, 2006
|
Viinikainen The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children. Epilepsy Behav 2006; 9:636-40
|
|
Vinten (Valproate), 2005
|
Adab The longer term outcome of children born to mothers with epilepsy. J. Neurol. Neurosurg. Psychiatry 2004; 75:1575-83 Vinten Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 2005; 64:949-54
|
|
Wen (Valproate) (Mixed indications), 2017
|
Wen X Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model. BMC Pregnancy Childbirth 2017;17:10
|
|
Wiggs (Epilepsy) (Valproate), 2024
|
Wiggs Specific Birth Defects Following Antiseizure Medications Used By Pregnant Women With Epilepsy. Neurol Clin Pract 2024; 14:e200289
|
|
Wood (Valproate), 2015
|
Nadebaum Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology 2011; 76:719-26 Wood Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy. Epilepsia 2015; 56:1047-55
|
|
Zhang (Valproate) (Epilepsy), 2020
|
Zhang Clinical characteristics and fetal outcomes in women with epilepsy with planned and unplanned pregnancy: A retrospective study. Seizure 2020; 79:97-102
|
